Cargando…
Humoral and cellular responses to SARS-CoV-2 vaccines before and after chimeric antigen receptor–modified T-cell therapy
Autores principales: | Gonzalez, Michael A., Bhatti, Atif M., Fitzpatrick, Kristin, Boonyaratanakornkit, Jim, Huang, Meei-Li, Campbell, Victoria L., Hecht, Jessica, Ibrahimi, Sarah, Wanner, Shera N., Green, Damian J., Maloney, David G., Gauthier, Jordan, Cowan, Andrew J., Greninger, Alexander L., Krantz, Elizabeth M., Koelle, David M., Hill, Joshua A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474406/ https://www.ncbi.nlm.nih.gov/pubmed/36094846 http://dx.doi.org/10.1182/bloodadvances.2022008338 |
Ejemplares similares
-
Comparison of Humoral and T-Cell Response after Sars-Cov-2 Vaccination Among Patients before and after Chimeric Antigen Receptor-Modified T Cell (CAR-T cell) Therapy
por: Gonzalez, Michael A, et al.
Publicado: (2022) -
Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapy
por: Walti, Carla S., et al.
Publicado: (2021) -
Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapy: a prospective observational study
por: Walti, Carla S, et al.
Publicado: (2021) -
196. Antibodies to Vaccine-preventable Infections After CAR-T Cell Immunotherapy for B Cell Malignancies
por: Walti, Carla S, et al.
Publicado: (2020) -
Antibodies against vaccine-preventable infections after CAR-T cell therapy for B cell malignancies
por: Walti, Carla S., et al.
Publicado: (2021)